![Mark Lampert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lampert
Vorstandsvorsitzender bei
BVF, Inc.
Profil
Mr. Mark N.
Lampert is a Chief Executive Officer at BVF Partners LP, a Chief Executive & Financial Officer & Secretary at BVF, Inc. and a President at BVF Partners OS Ltd. He is on the Board of Directors at AvMax, Inc. and Mendel Biotechnology, Inc.
Mr. Lampert was previously employed as a Head-Business Development by Cambridge NeuroScience, Inc., a Non-Executive Director by Biotica Technology Ltd., a Vice President by Oppenheimer & Co., Inc., and a Principal by The Boston Consulting Group, Inc. He also served on the board at CASCADIAN THERAPEUTICS INC, Acumen Pharmaceuticals, Inc., Athersys, Inc. /Old/ and Ziarco Pharma Ltd.
He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.
Aktive Positionen von Mark Lampert
| Unternehmen | Position | Beginn |
|---|---|---|
BVF, Inc.
 BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Vorstandsvorsitzender | 14.09.1993 |
AvMax, Inc.
 AvMax, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | - |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Direktor/Vorstandsmitglied | - |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Vorstandsvorsitzender | 01.11.1993 |
BVF Partners OS Ltd.
 BVF Partners OS Ltd. Real Estate DevelopmentFinance Provides real estate services | Präsident | - |
Ehemalige bekannte Positionen von Mark Lampert
| Unternehmen | Position | Ende |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Direktor/Vorstandsmitglied | 17.01.2017 |
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Direktor/Vorstandsmitglied | 12.03.2013 |
CeNeS Pharmaceuticals, Inc.
 CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals focusing on nerve cell survival & function | Corporate Officer/Principal | 31.12.1989 |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Mark Lampert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals focusing on nerve cell survival & function | Health Technology |
BVF, Inc.
BVF, Inc. Investment Banks/BrokersFinance Manages hedge funds and engages in investment business | Finance |
BVF Partners LP
BVF Partners LP Investment ManagersFinance BVF generally pursues value-oriented investment strategies, investing primarily in the marketable securities issued by biotechnology companies. The focus of the BVF strategy is on fundamental, bottom-up analysis of individual issuers based on the theory that market mispricing exist because market prices do not incorporate all knowable economic and other relevant data. | Finance |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Athersys, Inc. /Old/
 Athersys, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutic biological products | Health Technology |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genetic and chemical solutions for the agricultural markets | Commercial Services |
AvMax, Inc.
AvMax, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Ziarco Pharma Ltd.
Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BVF Partners OS Ltd.
BVF Partners OS Ltd. Real Estate DevelopmentFinance Provides real estate services | Finance |
Wählen Sie MarketScreener 
